Back to search

Article

A systematic method for detecting abnormal mRNA splicing and assessing its clinical impact in individuals undergoing genetic testing for hereditary cancer syndromes

2022-07-14

Abstract excerpt

<h4>ABSTRACT</h4> Nearly 14% of disease-causing germline variants result from disruption of mRNA splicing. Most (67%) DNA variants predicted in silico to disrupt splicing end up classified as variants of uncertain significance (VUS). We developed and validated an analytic workflow — Sp lice E ffect E vent R esolver (SPEER) — that uses mRNA sequencing to reveal significant deviations in splicing, pinpoints th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
71a946c1-1a57-5a12-90a7-c2a6ac6528e6
DOI
10.1101/2022.07.12.499782
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A systematic method for detecting abnormal mRNA splicing and assessing its clinical impact in individuals undergoing genetic testing for hereditary cancer syndromesDOI 10.1101/2022.07.12.499782
Select a neighboring publication to make it the new centre.